TY - JOUR
T1 - Diagnosis and treatment of Huntington's disease
AU - Folstein, S.
AU - Folstein, M.
N1 - Copyright:
Copyright 2004 Elsevier B.V., All rights reserved.
PY - 1981
Y1 - 1981
N2 - Huntington's disease (HD), formerly known as Huntington's chorea, was described in 1872 by George Huntington, an American physician. Huntington's disease is a disorder characterized by chorea and dementia usually beginning between the ages of 35 and 45 years and gradually worsening, ending in death an average of 15 years after onset. The most prominent neuropathologic finding is atrophy of the caudate nucleus and the putamen. Huntington's disease is the most frequent inherited neurologic disorder with a prevalence of 4 to 8 per 100,000. At least twice that many persons, the offspring of affected persons may develop HD at some time. This article reports the authors' experience of the systematic examination and treatment of 50 HD patients and more than 100 persons at risk.
AB - Huntington's disease (HD), formerly known as Huntington's chorea, was described in 1872 by George Huntington, an American physician. Huntington's disease is a disorder characterized by chorea and dementia usually beginning between the ages of 35 and 45 years and gradually worsening, ending in death an average of 15 years after onset. The most prominent neuropathologic finding is atrophy of the caudate nucleus and the putamen. Huntington's disease is the most frequent inherited neurologic disorder with a prevalence of 4 to 8 per 100,000. At least twice that many persons, the offspring of affected persons may develop HD at some time. This article reports the authors' experience of the systematic examination and treatment of 50 HD patients and more than 100 persons at risk.
UR - http://www.scopus.com/inward/record.url?scp=0019797767&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019797767&partnerID=8YFLogxK
M3 - Article
C2 - 6453680
AN - SCOPUS:0019797767
SN - 0098-8243
VL - 7
SP - 60
EP - 66
JO - Comprehensive Therapy
JF - Comprehensive Therapy
IS - 4
ER -